Effect of probiotics on the expression of Barrett's oesophagus biomarkers

Keyphrases

• Barrett's Esophagus 100%
• Esophageal Adenocarcinoma 66%
• In Cancer 33%
• Mortality Rate 33%
• Cyclooxygenase-2 33%
• Inhibitory Effect 33%
• Inhibitory Role 33%
• Squamous Epithelium 33%
• Barrett 33%
• Adenocarcinoma 33%
• Microorganisms 33%
• Disease Pathogenesis 33%
• Esophageal Cancer 33%
• Interleukin-18 (IL-18) 33%
• In Vitro Model 33%
• Gastrointestinal Diseases 33%
• Longum 33%
• Cancer Disease 33%
• Lactobacillus Acidophilus 33%
• Culture Conditions 33%
• Disease Rate 33%
• P53 Tumor Suppressor Gene 33%
• Esophageal Squamous Cell Carcinoma 33%
• Columnar 33%
• Gastroesophageal Junction 33%
• Complicated Conditions 33%
• Molecular Pathogenesis 33%
• CDX1 33%
• Homeobox 33%
• Therapeutic Culture 33%
• Probiotic Administration 33%
• Barrett's Disease 33%
• Esophageal Cancer Cells 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Probiotic Agent 100%
• Barrett Esophagus 100%
• Esophageal Adenocarcinoma 50%
• Disease 33%
• Malignant Neoplasm 16%
• Cyclooxygenase 2 16%
• Tumor Suppressor Protein 16%
• Tumor Necrosis Factor 16%
• Protein P53 16%
• Prevalence 16%
• Mortality Rate 16%
• Adenocarcinoma 16%
• Esophagus Cancer 16%
• Molecular Pathology 16%
• Interleukin 18 16%
• Gastrointestinal Disease 16%
• Lactobacillus acidophilus 16%

Immunology and Microbiology

• Probiotic 100%
• Esophagus 100%
• Tumor Suppressor Gene 16%
• Tumor Necrosis Factor 16%
• P53 16%
• Mortality Rate 16%
• Coculture 16%
• Prevalence 16%
• Squamous Epithelium 16%
• Gastroesophageal Junction 16%
• Interleukin 18 16%
• Lactobacillus acidophilus 16%
• Esophageal Cell Line 16%
• Homeobox 16%